Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yeah i liked how after xero volume for a few days it went to .0017 to close up 6%. nice and steady there on lite trading. if we can get a few hundred k volume here it may go.
bought 300k and think thats enough
not til I buy some more
nice little move here today after a few days of zero volume we moved up 6% on 110k shares. hopefully we move soon
what we closed?
300k here
i have a nice position at .001 are we going to move? zero attention the last few days
waiting on a breakout
whats going on here?
it might go tomorrow i dunno how many more shares they have. we could see another 50% spike tomorrow
I still want some more at .001 or less, there's been a generous bidwhacker lately
Are we finally going here. If the bid and ask are really .002x.003 we will gap and fly tomorrow
5 min chart looks weird....
lifegear,
can you put in a new intraday chart here!?
tia
no major interest as of now...who knows
well,UNBELIEVABLE!
got my ticket here
just look at what happened to TTNP closed at .05 and the next day opened up at 1.70 with GREAT news
that's mind boggling lol
grabbed some more @.001
hopefully next pharmaceutical runner like the other yesterday
1@.0017
1@.002
1@.0035
2@.004
1@.005
1@.009
grabbed some 200k
hope was worth
it's nice to accumulate around this level for the meantime
wow!
just wait for another FDA aproval like TTNP and VNDA did!? what they have n pipeline?
same share structur like the others?
Hey Life i sent the info private and since you mod I will give you the ACUS as good bet for double in the am. Delete if you do not want the symbol. Good luck Dave
Oops wrong board.
can't believe what happened to other drug plays... VNDA TTNP LJPC rocked hard
very much discounted imho
FDA approved ADHD drug-->
drug companies are flying lately like CTIC, maybe this could follow
Auriga Laboratories, Inc. (ARGA.OB) Announces FDA Approval of Liquadd(TM) Oral Solution for the Treatment of ADHD and Upcoming Product Launch
CAMARILLO, CA--(MARKET WIRE)--Mar 10, 2008 -- Auriga Laboratories, Inc. (OTC BB:ARGA.OB - News), a specialty pharmaceutical company, announced today the FDA approval of Liquadd(TM) (dextroamphetamine sulfate) Oral Solution 5 mg/5 mL indicated for the treatment of Attention Deficit Disorder with Hyperactivity (ADHD).
The ADHD market is valued at over $3.5 billion dollars, with approximately 35 million prescriptions written annually. Dextroamphetamine is one of the most frequently prescribed molecules for the treatment of ADHD. "Liquadd(TM) will now provide physicians the proven efficacy of dextroamphetamine in a unique new oral solution form, with our key target consisting of the estimated 5% to 10% of patients that have difficulty swallowing pills. We are excited about expanding the treatment options available to physicians by providing a dextroamphetamine treatment regimen in an easy to swallow form previously not available in the market," said Rick Coulon, Executive Vice President of Sales and Marketing of Auriga.
Liquadd(TM) will be launched during the 2nd Quarter of 2008.
http://www.biospace.com/news_story.aspx?NewsEntityId=88638
is ihub quote right? .002x.003 end of day?
still hopeful with this one, look at what happened to LIPD...
ARGA - Seeing a little more volume today...
That makes two of us. It is a perfect low float candidate for a huge momo run, just a matter of waiting for it to happen. One thing for sure, you have to pay a lot more (about 10X) for shares now than you did a couple months ago, accumulation???
Brad
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
308
|
Created
|
02/23/07
|
Type
|
Free
|
Moderators |
Auriga Laboratories
Auriga Laboratories™ develops pharmaceutical products based on patented drug delivery technologies in cellular biology, material science, and pharmaceutics. It offers Extendryl, which is used for the treatment of cough and cold medications, and allergy symptoms. The company also offers products for the treatment of gastrointestinal disorders and central nervous system disorders, including pain control. Auriga Laboratories is based in Norcross, Georgia. Auriga Laboratories™ is a specialty pharmaceutical company building an industry changing commission based-sales model. The company's high-growth business model combines driving revenues through a variable cost commission-based sales structure, acquisition of proven brand names, introduction of new brands, and a strategic development pipeline, all of which is designed to enhance its growing direct relationships with physicians nationwide.
Auriga Laboratories™ Inc. is a sales-focused specialty pharmaceutical company capitalizing on high-revenue markets and opportunities in the pharmaceutical industry through a variable cost commission-based sales structure, acquisition of proven brand names, introduction of new brands, and a strategic development pipeline. We are currently focused on delivering unique solutions for the respiratory, dermatology, and xerostomia (dry mouth) markets and enhancing our relationships with physicians nationwide.
Auriga's founders and management team are experts in managing the full life cycle of bringing a new medication to market - from pipeline development and formulation to final sales. Our drug development pipeline leverages novel material science and advanced drug delivery technologies to produce improved formulations of successful brands to further expand markets and sales for proven, successful products.
Auriga Milestones:
Computershare Trust Company, Inc.
350 Indiana Street, Suite 800
Golden, CO 80401
Share Structure
250,000,000 Shares Authorized
79,536,557 Outstanding Shares as of May 12, 2008
Company Website
http://www.aurigalabs.com
Investor Relations
805-437-7200
investors@aurigalabs.com
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |